Dotmatics licenses their integrated Suite of Solutions for Pre-Clinical Research Informatics to Basilea

Bishops Stortford, United Kingdom, May 8th 2012 - Dotmatics Ltd, a leading provider of informatics services to the pharmaceutical and biotechnology industries, today announced that Basilea Pharmaceutica International Ltd have licensed and globally deployed Dotmatics' entire suite of scientific informatics solutions for pre-clinical research data management.

The Dotmatics platform provides for registering, analyzing and managing scientific data, an electronic laboratory notebook for chemistry and biology experiments, the ability to query and report research data, and to visualize with chemical intelligence.

Basilea CSO, Laurenz Kellenberger, PhD, states, "With the integrated Dotmatics platform tailored to Basilea's specific needs, we are further enhancing the way we globally consolidate and learn from biological and chemical research data. We look forward to continue working with Dotmatics to efficiently address our future informatics requirements in chemistry and biology."

“We are really excited to have this opportunity to provide a suite of tools for global deployment in Basilea’s research group and to be able to collaborate with them,” said Stephen Gallagher, PHD and CEO of Dotmatics. “We are committed to delivering high quality solutions and services to ensure that the informatics requirements of Basilea’s R & D are fulfilled” he added.

Request a demonstration or
ask us a question